Paper41789618
Peroxisome proliferator‑activated receptor α regulates acesulfame‑K‑induced NAFLD via hepatic PLCβ: Foe and friend.
Lin PY and 14 others. Int J Mol Med, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Peroxisome proliferator‑activated receptor α regulates acesulfame‑K‑induced NAFLD via hepatic PLCβ: Foe and friend. Papers, record 41789618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41789618
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Peroxisome proliferator‑activated receptor α regulates acesulfame‑K‑induced NAFLD via hepatic PLCβ: Foe and friend.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| PPAR alpha | Major topic |
| Non-alcoholic Fatty Liver Disease | Major topic |
| Thiazines | Major topic |
| Liver | Major topic |
| Phospholipase C beta | Major topic |
| Animals | |
| Male | |
| Mice | |
| Mice, Knockout | |
| Humans | |
| Signal Transduction | |
| Mice, Inbred C57BL | |
| Diet, High-Fat | |
| Lipid Metabolism |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 42,563,700 | [Corrigendum] Peroxisome proliferator‑activated receptor α regulates acesulfame‑K‑induced NAFLD via hepatic PLCβ: Foe and friend. | https://conductscience.org/library/papers/42563700 |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11,781,357 | The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. | J Clin Invest | 2002 | https://conductscience.org/library/papers/11781357 | PubMed |
| 2 | 11,509,186 | Mammalian sweet taste receptors. | Cell | 2001 | https://conductscience.org/library/papers/11509186 | PubMed |
| 3 | 35,987,213 | Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. | Cell | 2022 | https://conductscience.org/library/papers/35987213 | PubMed |
| 4 | 41,373,582 | Role of ChREBP-PPARα-FGF21 Axis in Metabolic Dysfunction of MASLD. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373582 | PubMed |
| 5 | 36,922,598 | The dietary sweetener sucralose is a negative modulator of T cell-mediated responses. | Nature | 2023 | https://conductscience.org/library/papers/36922598 | PubMed |
| 6 | 33,582,884 | Pharmacology of TAS1R2/TAS1R3 Receptors and Sweet Taste. | Handb Exp Pharmacol | 2022 | https://conductscience.org/library/papers/33582884 | PubMed |
| 7 | 22,111,035 | The Role of the Sweet Taste Receptor in Enteroendocrine Cells and Pancreatic β-Cells. | Diabetes Metab J | 2011 | https://conductscience.org/library/papers/22111035 | PubMed |
| 8 | 36,527,474 | Down-regulation of hepatic CLOCK by PPARα is involved in inhibition of NAFLD. | J Mol Med (Berl) | 2023 | https://conductscience.org/library/papers/36527474 | PubMed |
| 9 | 17,495,045 | Sweet taste receptors in rat small intestine stimulate glucose absorption through apical GLUT2. | J Physiol | 2007 | https://conductscience.org/library/papers/17495045 | PubMed |
| 10 | 35,385,790 | Exendin-4 inhibits small intestinal glucose sensing and absorption through repression of T1R2/T1R3 sweet taste receptor signalling in streptozotocin diabetic mice. | Transl Res | 2022 | https://conductscience.org/library/papers/35385790 | PubMed |
| 11 | 27,636,730 | PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. | Nat Rev Endocrinol | 2017 | https://conductscience.org/library/papers/27636730 | PubMed |
| 12 | 30,721,958 | Effects of Sweeteners on the Gut Microbiota: A Review of Experimental Studies and Clinical Trials. | Adv Nutr | 2019 | https://conductscience.org/library/papers/30721958 | PubMed |
| 13 | 30,352,267 | Basal PPARα inhibits bile acid metabolism adaptation in chronic cholestatic model induced by α-naphthylisothiocyanate. | Toxicol Lett | 2019 | https://conductscience.org/library/papers/30352267 | PubMed |
| 14 | 36,948,701 | Molecular regulation of PLCβ signaling. | Methods Enzymol | 2023 | https://conductscience.org/library/papers/36948701 | PubMed |
| 15 | 33,989,548 | Mechanisms and disease consequences of nonalcoholic fatty liver disease. | Cell | 2021 | https://conductscience.org/library/papers/33989548 | PubMed |
| 16 | 37,251,331 | Therapeutic effect of fenofibrate for non-alcoholic steatohepatitis in mouse models is dependent on regime design. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37251331 | PubMed |
| 17 | 37,798,441 | Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease. | Nat Rev Gastroenterol Hepatol | 2024 | https://conductscience.org/library/papers/37798441 | PubMed |
| 18 | 41,385,862 | Chiglitazar, a PPAR pan-agonist: Impacts on type 2 diabetes mellitus and multi-system metabolic regulation - A review. | Biomed Pharmacother | 2025 | https://conductscience.org/library/papers/41385862 | PubMed |
| 19 | 12,444,865 | Molecular understanding of hyperglycemia's adverse effects for diabetic complications. | JAMA | 2002 | https://conductscience.org/library/papers/12444865 | PubMed |
| 20 | 37,552,302 | Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Liver Cancer and Chronic Liver Disease Mortality. | JAMA | 2023 | https://conductscience.org/library/papers/37552302 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41789618
GET https://conductscience.org/api/papers/v1/41789618/references?page=2